Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bluejay Diagnostics (BJDX) Share-based Compensation (2022 - 2023)

Historic Share-based Compensation for Bluejay Diagnostics (BJDX) over the last 2 years, with Q4 2023 value amounting to -$15565.0.

  • Bluejay Diagnostics' Share-based Compensation fell 11777.11% to -$15565.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $189244.0, marking a year-over-year decrease of 5629.52%. This contributed to the annual value of $20094.0 for FY2024, which is 8938.2% down from last year.
  • According to the latest figures from Q4 2023, Bluejay Diagnostics' Share-based Compensation is -$15565.0, which was down 11777.11% from -$42482.0 recorded in Q3 2023.
  • Over the past 5 years, Bluejay Diagnostics' Share-based Compensation peaked at $219589.0 during Q1 2023, and registered a low of -$42482.0 during Q3 2023.